Avingtrans (LON:AVG – Get Free Report) released its earnings results on Wednesday. The company reported GBX 32 EPS for the quarter, Digital Look Earnings reports. Avingtrans had a return on equity of 6.13% and a net margin of 4.54%.
Avingtrans Stock Performance
Shares of AVG stock traded up GBX 12.80 on Friday, hitting GBX 752.80. 135,646 shares of the stock traded hands, compared to its average volume of 112,043. The company has a debt-to-equity ratio of 23.26, a current ratio of 1.57 and a quick ratio of 1.87. The company has a market capitalization of £278.02 million, a PE ratio of 35.68 and a beta of 0.57. Avingtrans has a 1-year low of GBX 470 and a 1-year high of GBX 760. The company’s fifty day moving average is GBX 725.26 and its 200 day moving average is GBX 655.60.
Insiders Place Their Bets
In other Avingtrans news, insider Stephen McQuillan sold 157,500 shares of the stock in a transaction on Tuesday, July 28th. The shares were sold at an average price of GBX 710, for a total transaction of £1,118,250. Also, insider Stephen King sold 140,000 shares of the firm’s stock in a transaction dated Tuesday, July 28th. The stock was sold at an average price of GBX 710, for a total transaction of £994,000. Insiders own 13.57% of the company’s stock.
Avingtrans Company Profile
Avingtrans plc has a proven strategy of “buy and build” in highly regulated engineering markets, a strategy it has named “Pinpoint-Invest-Exit”. Significant shareholder value is delivered through a clear strategy, a strong balance sheet and an agile and experienced management team.
Avingtrans designs, manufactures and supplies original equipment, systems and associated aftermarket services to the energy, medical and industrial markets worldwide.
The Group has ten business units organised into three operating divisions: the Energy Divisions comprising Engineered Pumps & Motors (EPM) and Process Solutions & Rotating Equipment (PSRE) and the Medical Division.
Read More
- Five stocks we like better than Avingtrans
- Remitly’s September Pullback Tests a Still-Strong Growth Story
- Saddle Up: Texas Stock Exchange Ropes In $80 Billion in Listings
- Why Concentra’s Quiet Healthcare Business Keeps Winning
- Inhibrx’s Insider Buying Adds Fuel to a High-Short-Interest Biotech Setup
Receive News & Ratings for Avingtrans Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avingtrans and related companies with MarketBeat.com's FREE daily email newsletter.
